Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis - Related Studies

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis (TEMSO)

This study is ongoing, but not recruiting participants.

Study NCT00134563. Last updated on September 24, 2008. Information provided by Sanofi-Aventis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Multiple Sclerosis

2	Additional conditions recognized in this trial
		Sclerosis

3	More general conditions related to this trial
		Autoimmune Diseases
		Autoimmune Diseases of the Nervous System
		Demyelinating Autoimmune Diseases, CNS
		Demyelinating Diseases
		Immune System Diseases
		Nervous System Diseases
		Pathologic Processes

4	Interventions listed in this trial
		teriflunomide (HMR1726)
		placebo

5	Sponsors listed in this trial
		Sanofi-Aventis